glp 1 agonist history Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Comparing Ozempic, Wegovy and Other

Tirzepatide tolerance does not transfer cleanly to retatrutide because of the glucagon receptor

A meta-analysis across randomized controlled trials found significant reductions in body weight averaging 12.4%, BMI by 4.0 kg/m2, and waist circumference by 8.0 cm

This isnt a reason to avoid treatment, but its a variable worth tracking

Therefore, DPP-4 inhibitors extend the half-life of endogenous GLP-1 lead to a 2threefold elevation of endogenous GLP-1 concentration, and provide beneficial effects in T2DM [110, 111]

Weight regain is very common after stopping a GLP-1on average, up to two-thirds of the lost weight is regained within one year

Starting dose: 2.5 mg weekly (for 4 weeks) Titrated up in 2.5 mg increments every 4 weeks Common maintenance doses: 10 mg to 15 mg weekly Maximum studied dose: 15 mg weekly This slow escalation is designed to improve tolerance while still achieving substantial reductions in body weight and HbA1c